The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 2, 2009, Pages 289-292

  Ibrahim, Ashraf S ^a,b   Gebremariam, Teclegiorgis ^a   French, Samuel W ^a,b   Edwards Jr , John E ^a,b   Spellberg, Brad ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aspergillus fumigatus; IPA; LAmB

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; DEFERASIROX; PLACEBO;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; HISTOPATHOLOGY; IN VITRO STUDY; LUNG ASPERGILLOSIS; LUNG PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MOUSE; NONHUMAN; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 77950295230     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp426     Document Type: Article

References (10)

1. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002; 21: 161-72.
2. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
3. Hissen AH, Wan AN, Warwas ML et al. The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-pornithine N5-oxygenase, is required for virulence. Infect Immun 2005; 73: 5493-503.
4. Altes A, Remacha AF, Sarda P et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505-9.
5. Kontoyiannis DP, Chamilos G, Lewis RE et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303-6.
6. Ibrahim AS, Gebermariam T, Fu Y et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007; 117: 2649-57.
7. Sheppard DC, Rieg G, Chiang LY et al. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2004; 48: 1908-11.
8. Clinical Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi M38-A2. CLSI, Wayne, PA, USA, 2008.
9. Ibrahim AS, Edwards JE Jr, Fu Y et al. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 2006; 58: 1070-3.
10. Zarember KA, Cruz AR, Huang CY et al. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 2009; 53: 2654-6.